Advancing Vascular Health
Through Evidence-Based
Practice
From diagnostic insights to patient education materials—access the knowledge, tools, and clinical guidance that empowers better vascular care outcomes. Discover comprehensive tools and insights to advance your vascular practice—from clinical protocols and patient education to the latest research and treatment innovations.
Find More Resources In Our Community
Newest Topics
Superficial Vein Thrombosis
Newly Diagnosed Patients
September 16, 2025
In this review, blood clot size (> 5 centimeters) and location (<3 centimeters from a deep vein) matters. This directs the treatment choice of anticoagulation (fondaparinux, rivaroxaban) versus conservative management (warm compresses, ibuprofen, compression stockings).
Superficial Vein Thrombosis
Newly Diagnosed Patients
September 16, 2025
In this review, blood clot size (> 5 centimeters) and location (<3 centimeters from a deep vein) matters. This directs the treatment choice of anticoagulation (fondaparinux, rivaroxaban) versus conservative management (warm compresses, ibuprofen, compression stockings).
What is a Polygenic Risk Score (PGS) and why does it matter in lung cancer?
Newly Diagnosed Patients
August 26, 2025
A polygenic risk score is like a “genetic fingerprint” built from thousands of small DNA variations (SNPs). Each variant adds a tiny bit of risk, but when combined, they provide a powerful measure of a person’s inherited predisposition to certain diseases — including blood clots (venous thromboembolism, VTE).
What is a Polygenic Risk Score (PGS) and why does it matter in lung cancer?
Newly Diagnosed Patients
August 26, 2025
A polygenic risk score is like a “genetic fingerprint” built from thousands of small DNA variations (SNPs). Each variant adds a tiny bit of risk, but when combined, they provide a powerful measure of a person’s inherited predisposition to certain diseases — including blood clots (venous thromboembolism, VTE).
Popular Articles
Superficial Vein Thrombosis
Newly Diagnosed Patients
September 16, 2025
In this review, blood clot size (> 5 centimeters) and location (<3 centimeters from a deep vein) matters. This directs the treatment choice of anticoagulation (fondaparinux, rivaroxaban) versus conservative management (warm compresses, ibuprofen, compression stockings).
Superficial Vein Thrombosis
Newly Diagnosed Patients
September 16, 2025
In this review, blood clot size (> 5 centimeters) and location (<3 centimeters from a deep vein) matters. This directs the treatment choice of anticoagulation (fondaparinux, rivaroxaban) versus conservative management (warm compresses, ibuprofen, compression stockings).
What is a Polygenic Risk Score (PGS) and why does it matter in lung cancer?
Newly Diagnosed Patients
August 26, 2025
A polygenic risk score is like a “genetic fingerprint” built from thousands of small DNA variations (SNPs). Each variant adds a tiny bit of risk, but when combined, they provide a powerful measure of a person’s inherited predisposition to certain diseases — including blood clots (venous thromboembolism, VTE).
What is a Polygenic Risk Score (PGS) and why does it matter in lung cancer?
Newly Diagnosed Patients
August 26, 2025
A polygenic risk score is like a “genetic fingerprint” built from thousands of small DNA variations (SNPs). Each variant adds a tiny bit of risk, but when combined, they provide a powerful measure of a person’s inherited predisposition to certain diseases — including blood clots (venous thromboembolism, VTE).
Is It Closing Time? An Update on PFO & Stroke
Newly Diagnosed Patients
August 7, 2025
A July 2025 JAMA review highlights that PFO closure has shifted from a broad intervention to a more targeted therapy, with careful patient selection—guided by two key tools—at the heart of decision-making
Is It Closing Time? An Update on PFO & Stroke
Newly Diagnosed Patients
August 7, 2025
A July 2025 JAMA review highlights that PFO closure has shifted from a broad intervention to a more targeted therapy, with careful patient selection—guided by two key tools—at the heart of decision-making
The Intersection of Metabolic Pathways and Deep Vein Thrombosis
Newly Diagnosed Patients
July 3, 2025
As we think about the educational and scientific content we share on VLN, the intersection of VTE with metabolic disorders has come up repeatedly in our discussions. How and why would metabolic disorders influence thrombosis?
The Intersection of Metabolic Pathways and Deep Vein Thrombosis
Newly Diagnosed Patients
July 3, 2025
As we think about the educational and scientific content we share on VLN, the intersection of VTE with metabolic disorders has come up repeatedly in our discussions. How and why would metabolic disorders influence thrombosis?
Shedding Light on Bridging Therapy: A Deeper Dive into the AMBER Trial
Newly Diagnosed Patients
July 1, 2025
Alfonso J Tafur interviews McMaster University’s Dr. Alexander Godoy and Medical Student Tegvir Singh Grewal at ISTH 2025
Shedding Light on Bridging Therapy: A Deeper Dive into the AMBER Trial
Newly Diagnosed Patients
July 1, 2025
Alfonso J Tafur interviews McMaster University’s Dr. Alexander Godoy and Medical Student Tegvir Singh Grewal at ISTH 2025
Keep a Pulse on Progress
Explore our community and collaborate to build and utilize top-tier, trustworthy, and balanced medical education
Keep a Pulse on Progress
Explore our community and collaborate to build and utilize top-tier, trustworthy, and balanced medical education
Keep a Pulse on Progress
Explore our community and collaborate to build and utilize top-tier, trustworthy, and balanced medical education